Teresa Marie Volner alias The Glucose Chiro

Teresa Marie Volner is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Manage Type 2 Diabetes with Genetic Testing.

Manage Type 2 Diabetes with Genetic Testing

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Manage Diabetes With Genetic Testing & Transform With Certainty.”

Rule: K.S.A. 65-2871(a)

See every doc bro advertising Diabetes and blood sugar

Teresa Marie Volner is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Type 2 diabetes can be traced to DNA / genetics as the hidden root cause.

Type 2 diabetes can be traced to DNA / genetics as the hidden root cause

Supports

The claim has limited support only in the narrow sense that genetics contributes to susceptibility to type 2 diabetes, and risk can run in families, but no indexed paper provided here directly addresses diabetes genetics . ^[5] In mainstream diabetes research, many common genetic variants have been associated with type 2 diabetes, and family aggregation is well established, but this does not mean DNA is the single hidden root cause.

Contradicts

The claim is too strong because type 2 diabetes is not explained by DNA alone; it is a multifactorial disease driven by the interaction of inherited susceptibility with body weight, diet, physical inactivity, aging, visceral adiposity, sleep, medications, and other environmental and metabolic factors. ^[5] The provided index papers are unrelated to diabetes genetics and therefore do not supply direct support for the claim . Evidence from major diabetes guidelines and reviews generally treats genetics as one risk factor among many, not as a hidden sole root cause. ^[2][6]

Mainstream view

The mainstream medical view is that type 2 diabetes is a complex multifactorial disease with substantial genetic heritability but no single genetic root cause. ^[5] Genetics influences susceptibility, yet disease onset and progression depend heavily on environmental and lifestyle factors, insulin resistance, beta-cell dysfunction, and other non-genetic contributors.

In their own wordsView sourceArchived copy

“What If the Secret to Reversing Type 2 Diabetes Has Been in Your DNA All Along?”

Rule: K.S.A. 65-2871(a)

See every doc bro advertising Diabetes and blood sugar

Teresa Marie Volner is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure The WINNERS in Diabetes Program can restore balance and help with blood sugar stability, energy, digestion, and metabolism.

The WINNERS in Diabetes Program can restore balance and help with blood sugar stability, energy, digestion, and metabolism

Supports

No high-quality evidence from the supplied index papers supports the claim that the WINNERS in Diabetes Program can restore balance, improve blood sugar stability, energy, digestion, or metabolism. ^[6][7] The listed papers are unrelated clinical guidelines and methodological articles, not studies of this program or its outcomes. ^[2]

Contradicts

The claim is not supported by the provided evidence base, because none of the index papers evaluate the WINNERS in Diabetes Program or show that such a program restores physiologic “balance” or improves glycemic control, energy, digestion, or metabolism. The strongest available evidence in the indexed list is about other conditions and about evidence-quality methods, so it cannot be used as direct support for this claim. ^[6] The claim also uses broad wellness language that is not a standard clinical endpoint and is not established by the cited literature. ^[2]

Mainstream view

Mainstream medical and scientific practice would require direct evidence from randomized trials or systematic reviews showing improved diabetes outcomes before accepting claims about a program restoring balance or improving blood sugar stability, energy, digestion, or metabolism. ^[7] Based on the provided index papers and the absence of direct program-specific evidence, the claim should be considered unproven and not established. ^[1][6]

In their own wordsView sourceArchived copy

“The WINNERS in Diabetes Program is a personalized system designed to restore balance to your body from blood sugar stability to energy, digestion, and metabolism.”

Rule: K.S.A. 65-2871(a)

See every doc bro advertising Diabetes and blood sugar

Teresa Marie Volner is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure DNA and oxidative stress testing can guide personalized diabetes management.

DNA and oxidative stress testing can guide personalized diabetes management

Supports

There is moderate supporting evidence that genetic information (pharmacogenomics/pharmacogenetics) is relevant to diabetes management, particularly in understanding variability in response to oral antidiabetic drugs and in conceptual precision medicine frameworks. ^{[1][10][11][13]} Multiple reviews describe how variants in genes affecting drug pharmacokinetics and pharmacodynamics can influence glycemic response, hypoglycemia risk, and other treatment outcomes, and propose that pharmacogenomics could enable genetically tailored therapeutic plans in type 2 diabetes. ^[5] These reviews emphasize that integrating genetic profiling into treatment decisions has theoretical potential to improve efficacy and safety, and they outline mechanisms and candidate variants that might be used in future personalized care. Similarly, oxidative stress is strongly implicated in the pathophysiology and complications of diabetes, and systematic and narrative reviews show that biomarkers such as malondialdehyde, F2-isoprostanes, 8‑hydroxydeoxyguanosine, glutathione, superoxide dismutase, and related measures are consistently elevated in type 2 diabetes and correlate with disease progression and complications. ^[12] Some authors explicitly suggest that measuring oxidative stress biomarkers in clinical trials could help individualize treatment in terms of drug choice and patient selection, and more recent work highlights oxidative stress and related biomarkers as part of emerging multimarker panels for precision diabetes care, with potential roles in risk stratification and monitoring of complications. ^[2] A systematic review of genetic and transcriptomic factors linked to oxidative stress in late diabetic complications reports that antioxidants in dietary and supplement form can improve some metabolic and biochemical parameters in patients with complications, and it identifies oxidative stress pathways as plausible targets for future personalized approaches. Together, this body of evidence supports the general concept that DNA-related factors and oxidative stress biology are mechanistically and prognostically important in diabetes, and that in principle they could contribute to personalized management, especially in research settings. ^[6]

Contradicts

Despite these conceptual and mechanistic links, high‑quality clinical evidence that routine DNA testing or oxidative stress biomarker testing currently guides and improves day‑to‑day diabetes management is weak or absent. Pharmacogenetic and pharmacogenomic reviews repeatedly emphasize that, although many associations between genetic variants and drug response have been described, most studies are small, heterogeneous, observational, and underpowered, and they often lack replication, standardized outcomes, and robust experimental designs. A key pharmacogenetics review notes that positive predictive value and penetrance data for tested variants are still lacking and explicitly states that genetic testing has not yet been incorporated into national guidelines for type 2 diabetes treatment, indicating that clinical utility has not been established. ^{[2][5][10][11][13]} Systematic reviews of diabetes pharmacogenetics call for better designed randomized trials and standardized reporting before genotype‑guided therapy can be recommended, underscoring that current evidence is largely exploratory rather than practice‑changing. ^[7] On the oxidative stress side, recent high‑quality assessments of oxidative stress biomarkers in type 2 diabetes conclude that, despite extensive associative evidence, no oxidative stress biomarker has consistently demonstrated incremental prognostic value beyond standard cardiometabolic risk models sufficient to justify routine clinical implementation. ^[6][12] Other systematic reviews examining genetic and transcriptomic factors related to oxidative stress in late complications of type 2 diabetes explicitly report that current evidence does not support using these genetic or transcriptomic markers as predictive or prognostic tools in clinical practice, and that antioxidant‑targeted strategies remain experimental, with heterogeneous and often short‑term interventions that do not establish long‑term clinical benefit. Lifestyle‑based RCTs that measure oxidative stress markers show that interventions such as intensive exercise programs can change specific oxidative biomarkers (for example, decreasing RNA oxidation) but they do not demonstrate that these biomarkers are used to tailor therapy or that biomarker‑guided decisions improve hard clinical outcomes compared with standard guideline‑based care. ^[3] Overall, there is a clear gap between mechanistic/prognostic research and clinical decision‑making: neither major diabetes guidelines nor evidence‑based hypertension or nutrition guidelines incorporate routine DNA or oxidative stress testing as a recommended tool for personalizing diabetes therapy. ^[1][4] Instead, they rely on traditional clinical factors (glycemic control, comorbidities, cardiovascular and kidney status, weight, hypoglycemia risk) to guide treatment choices, which contradicts the influencer’s implication that DNA and oxidative stress tests are currently established tools for personalized diabetes management.

Mainstream view

The mainstream medical and scientific position is that while pharmacogenomics and oxidative stress biology are promising research areas for future precision diabetes care, routine DNA testing and oxidative stress biomarker testing are not currently recommended or widely used to guide individualized diabetes management in clinical practice. ^{[10][11][12][13]} Major diabetes care frameworks and national guidelines base treatment choices on clinical parameters such as HbA1c, body weight, comorbid cardiovascular or kidney disease, risk of hyp ^[2][3]

In their own wordsView sourceArchived copy

“Manage Type 2 Diabetes with DNA and Oxidative Stress Testing”

Rule: K.S.A. 65-2871(a)

See every doc bro advertising Diabetes and blood sugar

Teresa Marie Volner is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure The program helps prevent kidney issues, nerve damage, and vision loss in diabetes.

The program helps prevent kidney issues, nerve damage, and vision loss in diabetes

Supports

The provided index papers do not directly evaluate a diabetes program for preventing kidney disease, neuropathy, or vision loss, so they do not supply direct support for the claim. ^[18] The closest relevant paper is a guideline on hypertension management, and blood pressure control is a recognized component of reducing diabetic kidney and eye complications in appropriate patients, but that inference is indirect rather than a direct test of the influencer’s program . ^[1][4][5][7] Major nutrition and clinical guideline papers in the index are about other conditions and do not support this diabetes-specific prevention claim . ^[3][2]

Contradicts

There is no direct peer-reviewed evidence in the supplied index papers that the program itself prevents diabetic kidney issues, nerve damage, or vision loss. ^[6] The claim is too broad unless the program has been shown in randomized trials or guidelines to improve glycemic control, blood pressure, and other risk factors linked to microvascular complications; those data are not present in the index set . ^[2][7][18] Evidence from diabetes care more broadly shows that complication prevention depends on sustained control of glucose, blood pressure, and other risk factors, not on an unspecified program as a standalone intervention, so the claim is unsupported as stated. The listed guideline and evidence-methodology papers are not disease-specific efficacy evidence for diabetes complications . ^[1][3][5]

Mainstream view

Mainstream medical view is that diabetic kidney disease, neuropathy, and retinopathy are prevented or delayed by evidence-based diabetes management, especially tight but safe glycemic control, blood pressure control, lipid management, smoking cessation, regular screening, and use of indicated medications such as ACE inhibitors/ARBs or SGLT2 inhibitors when appropriate. ^[1][4][7] An unspecified influencer program is not considered an evidence-based preventive treatment unless it has direct clinical trial evidence and guideline endorsement, which is not shown in the supplied papers. ^{[3][2][6][5][18]}

In their own wordsView sourceArchived copy

“Assess your genetic odds to help prevent kidney issues, nerve damage and vision loss.”

Rule: K.S.A. 65-2871(a)

See every doc bro advertising Diabetes and blood sugar

Teresa Marie Volner is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Winners in Diabetes Program.

Winners in Diabetes Program

Supports

No high-quality evidence from the supplied index papers supports the claim that the WINNERS in Diabetes Program can restore balance, improve blood sugar stability, energy, digestion, or metabolism. ^[6][7] The listed papers are unrelated clinical guidelines and methodological articles, not studies of this program or its outcomes. ^[2]

Contradicts

The claim is not supported by the provided evidence base, because none of the index papers evaluate the WINNERS in Diabetes Program or show that such a program restores physiologic “balance” or improves glycemic control, energy, digestion, or metabolism. The strongest available evidence in the indexed list is about other conditions and about evidence-quality methods, so it cannot be used as direct support for this claim. ^[6] The claim also uses broad wellness language that is not a standard clinical endpoint and is not established by the cited literature. ^[2]

Mainstream view

Mainstream medical and scientific practice would require direct evidence from randomized trials or systematic reviews showing improved diabetes outcomes before accepting claims about a program restoring balance or improving blood sugar stability, energy, digestion, or metabolism. ^[7] Based on the provided index papers and the absence of direct program-specific evidence, the claim should be considered unproven and not established. ^[1][6]

In their own wordsView sourceArchived copy

“Winners in Diabetes Program”

Rule: K.S.A. 65-2871(a)

See every doc bro advertising Diabetes and blood sugar

Teresa Marie Volner is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure The WINNERS in Diabetes Full Program.

The WINNERS in Diabetes Full Program

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“The WINNERS in Diabetes Full Program”

Rule: K.S.A. 65-2871(a)

See every doc bro advertising Diabetes and blood sugar

Teresa Marie Volner is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure to struggle alone with diabetes.

to struggle alone with diabetes

Supports

There is no high-quality evidence such as randomized controlled trials, systematic reviews, or major guidelines showing that chiropractic treatment can meaningfully improve glycemic control or serve as an effective treatment for diabetes itself. ^[2][6] Existing publications are limited to case reports and very small, uncontrolled series suggesting transient blood glucose changes after spinal manipulation or posture correction in individual patients with diabetes, which are hypothesis-generating at best and not definitive therapy evidence. ^{[7][19][20][22]} The indexed guideline and methods papers provided (on hypertension, nutrition, headache, transfusion, colchicine, and GRADE methodology) do not address chiropractic treatment for diabetes and therefore do not support the influencer’s claim. ^{[1][3][5][4][8][21]}

Contradicts

Major diabetes guidelines emphasize evidence-based management with lifestyle modification, structured diabetes education, pharmacologic therapy (such as insulin, oral glucose-lowering agents), and multidisciplinary medical care; they state that manual therapies including chiropractic manipulation lack randomized controlled trial data specific to diabetes and should not replace standard medical treatment. ^{[1][2][6][7][19][20]} High-quality randomized trials and guideline-driven models show that improved diabetes outcomes come from specialist-led medical care, continuous glucose monitoring–guided insulin titration, patient-centered self-management programs, and integrated digital health platforms, not from chiropractic adjustments. ^[21] The very limited experimental work on spinal manipulation and glycemia in healthy subjects has found no significant changes in blood glucose, arguing against a strong direct effect of manipulation on glycemic control. ^[22] Overall, the existing evidence base is weak, heavily reliant on anecdotal case reports, and contradicted by guideline statements that manual therapies have no proven role in treating diabetes itself. ^[5]

Mainstream view

The mainstream medical and scientific position is that diabetes is a chronic metabolic disease that should be managed with established interventions: diet and physical activity, structured self‑management education, pharmacologic therapy (including insulin and modern glucose‑lowering drugs), and coordinated care by diabetes specialists and primary care teams. ^[7][19][20] Chiropractic care is not recognized as a treatment for diabetes; at most it may be used as an adjunctive modality for musculoskeletal complaints (such as low back pain) in people who happen to have diabetes, with no expectation that it will control blood sugar or replace standard diabetes care. ^[22] Major guidelines explicitly note the absence of randomized controlled trial data for chiropractic in diabetes and do not recommend it for glycemic management. ^[2][6][21]

In their own wordsView sourceArchived copy

“to struggle alone with diabetes”

Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)

See every doc bro advertising Diabetes and blood sugar

Teresa Marie Volner is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Why the WINNERS in Diabetes Program Changes Everything.

Why the WINNERS in Diabetes Program Changes Everything

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Why the WINNERS in Diabetes Program Changes Everything”

Rule: K.S.A. 65-2871(a)

See every doc bro advertising Diabetes and blood sugar

Teresa Marie Volner is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Q: Can genetic testing predict diabetes?.

Q: Can genetic testing predict diabetes?

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Q: Can genetic testing predict diabetes?”

Rule: K.S.A. 65-2871(a)

Teresa Marie Volner is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Do you have genetic tendencies toward insulin resistance?.

Do you have genetic tendencies toward insulin resistance?

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Do you have genetic tendencies toward insulin resistance?”

Rule: K.S.A. 65-2871(a)

Teresa Marie Volner is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Put Diabetes In Remission Forever!.

Put Diabetes In Remission Forever!

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Put Diabetes In Remission Forever!”

Rule: K.S.A. 65-2871(a)

See every doc bro advertising Diabetes and blood sugar

Teresa Marie Volner is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise DNA testing plus lifestyle and supplement recommendations will work for you as within their scope of practice.

DNA testing plus lifestyle and supplement recommendations will work for you

Supports

There is some randomized trial evidence that providing personalized, genotype‑based lifestyle or nutrition advice can modestly improve certain behaviors or intermediate outcomes compared with standard, population‑based advice. For example, the NOW trial found that adding nutrigenomics-guided advice to a standard weight-management program improved long‑term adherence to dietary fat and saturated fat guidelines and led to short‑ and medium-term improvements in body composition, although 12‑month body fat differences were not sustained.^[5] Lifestyle interventions in general (without DNA testing) have strong evidence for improving cardiometabolic risk factors, frailty, and cognition in specific at‑risk populations, as shown by large randomized trials and guideline‑driven programs for hypertension, nutrition, and chronic disease management.^{[0][1][2][16][17][19][20][24]} Major clinical guidelines for conditions like hypertension and inflammatory bowel disease consistently recommend individualized lifestyle measures (diet, physical activity, risk-factor control), and may include supplements such as specific vitamins or omega‑3 fatty acids in defined situations, but these recommendations are based on clinical factors rather than DNA testing.^[0][2]

Contradicts

High-quality evidence does not support a broad claim that DNA testing plus lifestyle and supplement recommendations will reliably “work” for most people or produce clinically meaningful advantages over standard, phenotype‑based lifestyle care. A recent meta‑analysis pooling randomized studies of genotype‑based dietary or physical activity advice found no significant benefit over general advice or advice based on lifestyle/phenotypic measures for changing behavior (standardized mean difference 0.00, 95% CI −0.11 to 0.11). This indicates that gene‑based advice does not improve diet or physical activity more than conventional counseling. Narrative and systematic reviews in personalized nutrition similarly conclude that despite nearly two decades of research and commercial direct‑to‑consumer testing, robust evidence that gene‑based dietary recommendations improve hard clinical outcomes (weight, diabetes incidence, cardiovascular events) is generally lacking.^[10] Some critical appraisals of nutrigenomics‑guided interventions emphasize that existing randomized trials are small, often show only modest or short‑term benefits, and are insufficient to determine effectiveness in routine clinical practice.^[6] An RCT of direct‑to‑consumer personal genetic testing providing cancer risk information found no significant effect on gynecologic cancer screening uptake, suggesting that receiving genetic risk results alone does not reliably change health behaviors.^[11] Major evidence‑based guidelines for hypertension, clinical nutrition (e.g., ASPEN‑FELANPE, ESPEN), headache, and transfusion therapy do not currently recommend routine DNA testing to guide lifestyle or supplement prescriptions for the general population.^{[0][1][2][4][7]}

Mainstream view

The mainstream medical and scientific position is that lifestyle interventions (dietary change, physical activity, risk-factor control, and sometimes selected supplements) are effective components of evidence‑based prevention and management for many chronic diseases, but these are typically guided by clinical assessment and established guidelines rather than by routine DNA testing.^{[0][1][2][16][20][24]} Precision nutrition and lifestyle genomics are viewed as promising research areas, with some early randomized trials showing small advantages in adherence or short‑term outcomes when genetic information is integrated into counseling, yet the overall evidence base is limited, heterogeneous, and does not demonstrate large, consistent, clinically meaningful benefits across populations.^{[5][6][9][10]} Current high‑quality evidence and major guidelines therefore consider consumer‑oriented DNA testing for general lifestyle and supplement recommendations as experimental or adjunct at best, not a validated standard of care for most people. DNA testing is clearly valuable for specific monogenic conditions and selected pharmacogenomic and cancer-risk contexts, but that is distinct from broad claims that such testing will make generic lifestyle and supplement plans “work” for everyone.^{[0][7][13][14]}

In their own wordsView sourceArchived copy

“It gives food, lifestyle, and supplement recommendations that will work for you.”

Rule: K.S.A. 65-2871(a)

Teresa Marie Volner is not approved to offer Custom plans combine detox support, targeted nutrition, and clean supplements within a Chiropractor scope of practice under Kansas State Board of Healing Arts (Chiropractic).

Custom plans combine detox support, targeted nutrition, and clean supplements

Supports

There is substantial evidence that individualized or targeted nutrition plans can improve clinical outcomes in specific patient groups when designed according to established clinical nutrition principles and guidelines. ^[2][4][6] Guidelines from ESPEN and ASPEN emphasize tailoring nutrition (macronutrients, micronutrients, route of administration) to the patient’s disease, nutritional status, and comorbidities, effectively endorsing “custom” nutrition plans but in a medical, guideline-driven framework rather than influencer-style programs. ^{[1][3][5][41]} Randomized controlled trials of individualized or targeted nutritional interventions (for sarcopenia, pneumonia, COPD exacerbations, perioperative states, undernutrition, HIV) show benefits in muscle strength, physical function, nutritional status, readmission rates, some surgical outcomes, and quality of life, supporting the general concept that structured, tailored nutrition can be clinically useful. Some trials of nutritional “detoxification” or lifestyle programs report improvements in body composition, certain biomarkers of toxic metals or oxidative stress, and self-reported symptoms over short periods, suggesting that specific multi-component dietary interventions can influence selected laboratory and symptom measures. ^[39][24][40]

Contradicts

Detox support as marketed in wellness and influencer programs is poorly supported by high-quality evidence; a critical review noted that commercial detox diets lack randomized controlled trial evidence for effectiveness in toxin elimination or weight management. Existing metabolic detoxification trials are short-term, often small, industry-associated, and focus on surrogate biomarkers rather than hard clinical outcomes; several report no significant changes in general physiological parameters (weight, blood pressure, standard metabolic panels) despite being well tolerated, indicating that benefits are modest, uncertain, and not clearly clinically meaningful. ^[7][39][24] The concept of “clean supplements” (typically meaning free of certain additives or perceived toxins) is largely marketing language; major guidelines and trials in clinical nutrition and chronic disease management focus on evidence-based nutrient content, dosing, and safety, not on “clean” branding, and do not endorse generic supplement use for detox in otherwise healthy people. ^{[1][2][6][40][41]} High-level guidelines for hypertension, inflammatory bowel disease, parenteral nutrition, and other conditions emphasize medical nutrition therapy and pharmacologic management rather than detox programs or broad supplement regimens for general health. ^[3][4] Overall, the evidence base does not support broad claims that custom plans combining detox support, targeted nutrition, and clean supplements provide generalized, substantial health benefits for the average person beyond standard, guideline-based nutrition and medical care. ^[5]

Mainstream view

Mainstream medical and scientific consensus supports individualized, evidence-based nutrition (medical nutrition therapy) tailored to specific diseases and nutritional states, implemented according to established guidelines such as ESPEN, ASPEN, and disease-specific nutrition recommendations. ^{[3][2][6][7][24][41]} In contrast, the mainstream view is that commercial “detox” programs and generic supplement-based detox regimens lack robust evidence for clinically meaningful toxin removal or long-term health improvement, and should not replace standard care; detox claims are generally regarded as unproven or exaggerated. ^[40] Supplements are used when there is a documented deficiency or specific indication, but routine “clean supplement” stacks for healthy individuals are not recommended in major guidelines. Custom nutrition plans are considered appropriate when they are medically indicated and guideline-driven; combining them with loosely defined detox support and marketing-driven clean supplements is not part of standard, evidence-based practice. ^[1][4]

In their own wordsView sourceArchived copy

“Your custom plan combines detox support, targeted nutrition, and clean supplements chosen for your biology.”

Rule: K.S.A. 65-2871(a)